Pierre Massion
Faculty Member
Last active: 1/11/2018

  1. Early involvement of the phosphatidylinositol 3-kinase/Akt pathway in lung cancer progression. Massion PP, Taflan PM, Shyr Y, Rahman SM, Yildiz P, Shakthour B, Edgerton ME, Ninan M, Andersen JJ, Gonzalez AL (2004) Am J Respir Crit Care Med 170(10): 1088-94
    › Primary publication · 15317667 (PubMed)
  2. Cardiomyocyte-restricted overexpression of endothelial nitric oxide synthase (NOS3) attenuates beta-adrenergic stimulation and reinforces vagal inhibition of cardiac contraction. Massion PB, Dessy C, Desjardins F, Pelat M, Havaux X, Belge C, Moulin P, Guiot Y, Feron O, Janssens S, Balligand JL (2004) Circulation 110(17): 2666-72
    › Primary publication · 15492314 (PubMed)
  3. 15-Lipoxygenase-2 expression in benign and neoplastic lung: an immunohistochemical study and correlation with tumor grade and proliferation. Gonzalez AL, Roberts RL, Massion PP, Olson SJ, Shyr Y, Shappell SB (2004) Hum Pathol 35(7): 840-9
    › Primary publication · 15257547 (PubMed)
  4. The molecular basis of lung cancer: molecular abnormalities and therapeutic implications. Massion PP, Carbone DP (2003) Respir Res : 12
    › Primary publication · 14641911 (PubMed) · PMC314397 (PubMed Central)
  5. Significance of p63 amplification and overexpression in lung cancer development and prognosis. Massion PP, Taflan PM, Jamshedur Rahman SM, Yildiz P, Shyr Y, Edgerton ME, Westfall MD, Roberts JR, Pietenpol JA, Carbone DP, Gonzalez AL (2003) Cancer Res 63(21): 7113-21
    › Primary publication · 14612504 (PubMed)
  6. Proteomic patterns of tumour subsets in non-small-cell lung cancer. Yanagisawa K, Shyr Y, Xu BJ, Massion PP, Larsen PH, White BC, Roberts JR, Edgerton M, Gonzalez A, Nadaf S, Moore JH, Caprioli RM, Carbone DP (2003) Lancet 362(9382): 433-9
    › Primary publication · 12927430 (PubMed)
  7. From clinical and pathologic to molecular staging of lung cancer. Massion PP, Carbone DP (2003) Am J Respir Crit Care Med 167(12): 1587-8
    › Primary publication · 12796051 (PubMed)
  8. Machine learning models for lung cancer classification using array comparative genomic hybridization. Aliferis CF, Hardin D, Massion PP (2002) Proc AMIA Symp : 7-11
    › Primary publication · 12463776 (PubMed) · PMC2244172 (PubMed Central)
  9. Genomic copy number analysis of non-small cell lung cancer using array comparative genomic hybridization: implications of the phosphatidylinositol 3-kinase pathway. Massion PP, Kuo WL, Stokoe D, Olshen AB, Treseler PA, Chin K, Chen C, Polikoff D, Jain AN, Pinkel D, Albertson DG, Jablons DM, Gray JW (2002) Cancer Res 62(13): 3636-40
    › Primary publication · 12097266 (PubMed)
  10. Secretory component production by human bronchial epithelial cells is upregulated by interferon gamma. Godding V, Sibille Y, Massion PP, Delos M, Sibille C, Thurion P, Giffroy D, Langendries A, Vaerman JP (1998) Eur Respir J 11(5): 1043-52
    › Primary publication · 9648953 (PubMed)